Stryker

289 articles with Stryker

• CD NXT power tool system empowers surgeons through real-time depth measurement

  3/2/2023

  Stryker announced the launch of its CD NXT System, the latest innovation in the company's power tools.

• Stryker’s Q Guidance System for cranial applications receives FDA clearance

  2/17/2023

  Stryker, one of the world’s leading medical technology companies, announced that its Q Guidance System with Cranial Guidance Software received 510 clearance from the U.S. Food and Drug Administration.

• Stryker reports 2022 operating results and 2023 outlook

  1/31/2023

  Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022.

• Stryker to host conference call on January 31, 2023

  12/28/2022

  Stryker announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update.

• Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process

  12/13/2022

  Stryker (NYSE:SYK) today announced the launch of Citrefix™, a suture anchor system for foot and ankle surgical procedures.

• Stryker declares a $0.75 per share quarterly dividend

  12/7/2022

  Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable January 31, 2023 to shareholders of record at the close of business on December 30, 2022, representing an increase of  7.9% versus the prior year and previous quarter.  

• Stryker opens the OR of the Future for customers to experience tomorrow's OR today

  11/14/2022

  Stryker, one of the world's leading medical technology companies, unveiled the OR of the Future—a model operating room inside Stryker's Flower Mound facility, providing a one-of-a-kind interactive experience for customers to conceptualize new OR design and technology.

• Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference

  11/3/2022

  Stryker will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022.

• Stryker reports third quarter 2022 operating results

  10/31/2022

  Stryker (NYSE:SYK) reported operating results for the third quarter of 2022.

• Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting

  10/12/2022

  Stryker, one of the world’s leading medical technology companies, will feature its suite of procedural solutions for spinal surgery, including its award-winning Q Guidance System with Spine Guidance Software, during the North American Spine Society annual meeting in Chicago, Oct. 12–15.

• Stryker Launches Monterey AL Interbody System with New Pre-clinical Data

  10/4/2022

  Stryker announced the launch of the Monterey AL Interbody System, a stand-alone interbody fusion device designed for anterior lumbar interbody fusion.

• Stryker to host conference call on October 31, 2022

  9/29/2022

  Stryker announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending September 30, 2022 and provide an operational update.

• Stryker Launches Q Guidance System with Spine Guidance Software

  9/27/2022

  Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today the launch of its Q Guidance System for spine applications.

• 

  FDA Review: ClearPoint Neuro, Oncopeptides, Iterative Scopes and More

  9/23/2022

  The U.S. FDA had a busy week with a range of drug approvals, advisory committee meetings and classification announcements.

• Stryker receives FDA clearance for OptaBlate™ Bone Tumor Ablation System

  9/20/2022

  Stryker announced today that its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. Food and Drug Administration.

• Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting

  9/14/2022

  Stryker (NYSE:SYK) today announced the launch of its Pulse Intelligent Delivery Platform, a full-circle product and fulfillment offering optimized for high volume foot and ankle procedures in the ambulatory surgery center (ASC) setting, which will debut at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting (AOFAS).

• Stryker Launches New Gamma4 Hip Fracture Nailing System

  9/1/2022

  Stryker has launched the Gamma4 System, strengthening the product’s 30-year legacy of continuous innovation and clinical history.

• Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference

  8/22/2022

  Stryker (NYSE:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022.

• 

  What Employers Really Look For in Medical Sales Candidates

  8/12/2022

  BioSpace spoke with Jay Johnson, the Director of Talent Acquisition for Orthopedics at Stryker, to find out what it takes to land a job in medical sales.

• Stryker reports second quarter 2022 operating results

  7/26/2022

  Stryker (NYSE:SYK) reported operating results for the second quarter of 2022.